Special Issues
Pharmaceutics publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Application of Marine-Derived Polymers in Drug Dosage Forms
Deadline: 20 October 2026
Biopolymer Nanoparticles for Targeted Therapy in Cardiovascular Diseases
Deadline: 20 October 2026
Targeted Therapies and Drug Delivery for Neurodegenerative Diseases
Deadline: 20 October 2026
Vesicle-Based Drug Delivery Systems
Deadline: 20 October 2026
Recent Advances in Antimicrobial Drug Delivery
Deadline: 20 October 2026
Advanced Nanotechnology-Based Strategies for Ocular Diseases Treatment
Deadline: 20 October 2026
Cutting-Edge Drug Delivery and Nanomedicine: Innovations in Hybrid Systems, Theranostics and Targeted Therapies
Deadline: 25 October 2026
Population Pharmacokinetics and Its Clinical Applications, 2nd Edition
Deadline: 25 October 2026
Solid Dispersions for Drug Delivery: Development, Preparation and In Vitro/In Vivo Characterization, 2nd Edition
Deadline: 25 October 2026
Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and Applications
Deadline: 29 October 2026
Topical Drug Delivery for Skin Diseases
Deadline: 30 October 2026
Development and Optimization of Buccal Films Formulations
Deadline: 31 October 2026
of 36

